Andrea Ganna, PhD

Andrea is a FIMM-EMBL group leader at Institute for Molecular Medicine Finland (FIMM) and a research associate at Massachusetts General Hospital, Harvard Medical School. Andrea’s research interests lie at the intersection between epidemiology, genetics, and statistics. He leads a diverse group of 18 researchers including biologists, mathematicians, and medical doctors. He is a winner of an ERC starting grant and the Leena Peltonen Prize for Excellence in Human Genetics. He is co-leading two major international consortia: the COVID-19 host genetic initiative, the largest human genetic study of COVID-19, and the INTERVENE consortium, which aims to integrate AI and human genetics tools for disease prevention and diagnosis across biobanks in Europe. He has also initiated the FinRegistry project, one of the most comprehensive registry-based health studies in the world. His research vision is to integrate genetic data and electronic health records to enhance the early detection of common diseases and improve public health interventions.